ReviewFrontiers in immunology2020

Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

Ebru Aydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.